Abzena enables the development of better treatments for patients, through its work with the top biopharmaceutical companies and academic groups worldwide.

Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting neoantigens

ACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents to support the development of target therapeutics, vaccines, and diagnostics

Actimed is leading the way in developing innovative therapies for the unmet medical need of cachexia, ALS and muscle wasting disorders.

Adaptate Biotherapeutics is developing therapeutic antibodies to harness the unique power of gamma delta T cells for next generation immunotherapy.

Adaptimmune, a leader in cell therapy, is a late-stage biopharmaceutical company, with a pipeline of therapies in clinical trials in 10 solid tumors.